Syndi Seinfeld
Neurology with Special Qualifications in Child Neurology · Hollywood, FLNPI 1346450384
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Livanova USA, Inc. at 46.7% of the total. Reporting peaked in 2019 at $34,810 and has fallen 90.8% since, to $3,186 in 2025.
Across 116 payments — averaging $445.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$24K
- Aquestive Therapeutics, Inc.$8K
- Mallinckrodt Enterprises LLC$7K
- Otter Pharmaceuticals, LLC$5K
- BTG International Inc.$3K
- Biocodex, Inc.$2K
- plus $3K from 9 others
Across 18 payments — averaging $5432.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aquestive Therapeutics, Inc.$83K
- Eisai Inc.$10K
- Livanova USA, Inc.$5K
What the payments were for
- Consulting fees$18,85336%
- Speaking & faculty fees$23,11345%
- Travel & lodging$4,0898%
- Food & beverage$5,65811%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 35 | $24,145 |
| Aquestive Therapeutics, Inc. | 5 | $7,803 |
| Mallinckrodt Enterprises LLC | 5 | $6,722 |
| Otter Pharmaceuticals, LLC | 5 | $5,483 |
| BTG International Inc. | 2 | $2,546 |
| Biocodex, Inc. | 4 | $1,947 |
| UCB, Inc. | 26 | $967 |
| Jazz Pharmaceuticals Inc. | 10 | $655 |
| Upsher-smith Laboratories LLC | 6 | $362 |
| Neuropace, Inc. | 4 | $294 |
| Catalyst Pharmaceuticals, Inc. | 4 | $269 |
| Neurelis, Inc. | 4 | $239 |
| Eisai Inc. | 2 | $137 |
| Greenwich Biosciences, Inc. | 3 | $135 |
| Acadia Pharmaceuticals Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$22,252
- SYMPAZAN$10,298
- LIBERVANT$2,925
- DIACOMIT$1,859
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$1,341
- Fycompa$346
- VNS - Sentiva$250
- Epidiolex$250
- RNS Neurostimulator Kit$121
How this compares
$51,729 in reported general payments places this provider in the 85th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Other neurology with special qualifications in child neurology in Hollywood
- Paul WinnerWest Palm Beach$624K
- Omer Abdul HamidOrlando$283K
- Natalie GillsonFort Myers$250K
- Trevor ResnickMiami$230K
- Migvis MonduyMiami$188K
- Elza VasconcellosMiami$170K
- Ronald DavisWinter Park$154K
- Ian MillerMiami$104K
- Michael HammerSaint Petersburg$100K
- Matt LallasMiami$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.